Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
Phase 4
Completed
- Conditions
- Type II Diabetes Mellitus
- Registration Number
- NCT00306176
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Brief Summary
The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Type II diabetes mellitus
- Poor glycemic control
Read More
Exclusion Criteria
- Heart failure
- Renal disease
- Liver disease
- Cardiovascular event
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Cardiovascular risk factors alterations
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AHEPA University Hospital of Thessaloniki
🇬🇷Thessaloniki, Greece